Evidence map›Paper›PMID 10449483›Full record

ArticleJournal of clinical microbiology1999

Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test.

J J Walls, M Aguero-Rosenfeld, J S Bakken, J L Goodman, D Hossain, R C Johnson, J S Dumler

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Human Granulocytic Anaplasmosis as a COVID-19 Mimicker.European journal of case reports in internal medicine · 2021
    Article
  3. Review
  4. Article
  5. Associated Factors to Seroprevalence ofJournal of tropical medicine · 2016
    Article
  6. Human granulocytic anaplasmosis.Infectious disease clinics of North America · 2015
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Serological evidence for human granulocytic ehrlichiosis in Western Austria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2003
    Article
  15. Article
  16. Article
  17. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay.Clinical and diagnostic laboratory immunology · 2001
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

J J WallsDivision of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
M Aguero-Rosenfeld
J S Bakken
J L Goodman
D Hossain
R C Johnson
J S Dumler
University of Minnesota · USYork University · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Virulence and Immunity of Granulocytic EhrlichiaeR01AI041213 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DUMLER, JOHN STEPHEN · 1996 to 2005
$1.3M
NIAID NIH HHS R01 AI041213NIAID NIH HHS R01 AI41213-01
6 · The paper itself

Abstract

Human granulocytic ehrlichiosis (HGE) is usually diagnosed by immunofluorescent antibody (IFA) serology with Ehrlichia equi-infected neutrophils or HGE agent-infected cultured HL60 cells. The HGE agent and E. equi are antigenically diverse, and interpretation of serologic results is also often variable. Thus, we investigated the sensitivity and specificity of various HGE agent and E. equi antigens used for IFA diagnosis by three different laboratories. Serum samples from 28 patients with well-characterized HGE and 9 patients with suspected HGE who were investigated by PCR, blood smear examinations, and serology were used, along with 9 serum samples from patients with other rickettsial and ehrlichial infections. Each serum sample was tested with up to 10 different antigen preparations. Overall, qualitative IFA results agreed in 70% of the samples. Titers among antigens were similar (r = 0.89 to 0. 96), but titers of individual samples varied by fourfold or more in 5 of 81 (6%) of the serum samples. Sensitivity ranged from 100% to 82%, and specificity varied from 100% to 67%, but these differences were not significant, even among those tested in the same laboratory or between two different laboratories. Antibodies were detected in 14 to 44% of acute-phase sera from confirmed HGE patients. Most false-positive reactions resulted with Ehrlichia chaffeensis; when these sera were excluded, the specificity of most antigens was 91 to 100%. These data indicate that IFA results often agree and that IFA is useful for diagnosis of HGE in convalescence. However, without further standardization, variability among serologic tests using E. equi and HGE agent isolates for diagnosis of HGE will occasionally provide discrepant results and confound diagnosis.

Indexed as

Antibodies, BacterialCross ReactionsEhrlichiaEhrlichiosisFluorescent Antibody TechniqueHumansImmunoglobulin GImmunoglobulin MSensitivity and SpecificitySerologic TestsAntibodies, BacterialImmunoglobulin GImmunoglobulin M

Identifiers

PMID10449483
PMCPMC85424
OpenAlexW2108437853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.